Related Experiment Video
Updated: Oct 12, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Improvement of Ejection Fraction in Patients undergoing Coronary Artery Bypass Grafting with Impaired Left
N Rajbhandari1, S Sharma Parajuli2, A Thakur1
1Department of Cardiac Surgery, Shahid Gangalal National Heart Centre, Bansbari, Kathmandu, Nepal.
Insights
Coronary artery bypass surgery significantly improves left ventricular ejection fraction in patients with impaired heart function. This myocardial revascularization enhances cardiac function and survival rates.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardiovascular Research
Background:
- Myocardial revascularization surgery offers superior long-term survival compared to medical therapy for patients with impaired left ventricular function.
- Left ventricular ejection fraction (LVEF) is a critical indicator of cardiac health and prognosis.
Purpose of the Study:
- To evaluate the change in LVEF 90 days post-coronary artery bypass surgery (CABS) in patients with preoperative LVEF ≤ 45%.
- To assess the impact of CABS on myocardial function in a Nepalese cardiac center.
Main Methods:
- A prospective study included 55 patients undergoing CABS with preoperative LVEF ≤ 45%.
- Preoperative and 90-day postoperative LVEF were compared using statistical analysis.
- Patients with immediate postoperative mortality or loss to follow-up were excluded.
Main Results:
- The mean LVEF improved significantly from 37.12±5.69% preoperatively to 45.80±10.00% at 90 days postoperatively (p=0.000).
- Triple vessel disease was most common (83.6%), with an average of 4 grafts placed per patient.
- A statistically significant improvement in LVEF was observed.
Conclusions:
- Surgical myocardial revascularization effectively improves LVEF in patients with preoperative left ventricular dysfunction.
- CABS is recommended for patients with low ejection fraction to enhance myocardial function and potentially improve survival rates.
Abstract:
Background Myocardial revascularization surgery has shown better long term survival expectancy compared to medical therapy in patient with impaired left ventricular function. Objective To evaluate the change in ejection fraction after 90 days in patients who underwent coronary artery bypass surgery and had preoperative left ventricular ejection fraction of less than and equal to 45% in a single cardiac center of Nepal over the period of 2 years. Method Out of 82 eligible patients during 2 years, 3 patients expired in immediate postoperatively and 24 patients had loss of 90 days' follow up. So, they were excluded from the study. Total 55 patients were taken for the study for whom statistical analysis was done to compare preoperative ejection fraction with post-operative 90 days' ejection fraction. Result Single vessel disease was present in 2(3.6%) patients, double vessel disease in 7(12.7%) patients and triple vessel disease in 46(83.6%) of the patients. In 2(3.6%) patients 2 grafts, in 18(32.7%) patients 3 grafts, in 33(60%) patients 4 grafts and in 2(3.6%) patients 5 grafts were placed for revascularization. The mean left ventricular EF in preoperative patients was 37.12±5.69% which improved to 45.80±10.00% in postoperative follow up at 90 days which was statistically significant (p=0.000). Conclusion Surgical revascularization of myocardium in preoperatively impaired left ventricular function patients helps improve left ventricular ejection fraction postoperatively. So we suggest surgical revascularization in patient with low ejection fraction for improvement of myocardial function. Hence improve survival rate in these patients.
More Related Videos
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy